ImmunologybioRxivPreprint
Targeting of the NLRP3 Inflammasome for early COVID-19
C. Marchetti, K. Mould, I. W. Tengesdal…·C. A. Dinarello
This study identifies early NLRP3 inflammasome activation in COVID-19 patients, linking it to cytokine release syndrome and suggesting NLRP3 as a therapeutic target.
DOI 10.1101/2021.02.24.432734